War on Disease
War on Disease
Invite
Back to Treatments
Treatment
Belimumab
1
Conditions
63
Trials
5,000
Participants
55%
Average Safety
Condition Evidence
Lupus
63 trials Β· 5,000 participants
75% effectiveness Β· 55% safety
Belimumab | DFDA